| Literature DB >> 32642100 |
Abstract
BACKGROUND: The purpose of this study was to evaluate the surgical outcome of uniportal video-assisted thoracoscopic surgery (VATS) for the treatment of non-small cell lung cancer performed by a surgeon who did not have previous experience performing open thoracotomy and multiportal VATS.Entities:
Keywords: Uniportal video-assisted thoracoscopic surgery (uniportal VATS); lung cancer; surgical outcome
Year: 2020 PMID: 32642100 PMCID: PMC7330296 DOI: 10.21037/jtd-20-242
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 3.005
Figure 1Working incision for right upper lobectomy (A) and right upper lobe apical segmentectomy (B). Working incision with thoracoscope and instruments (C) and closed incision with chest tube after right upper lobectomy (D).
Figure 2Surgical techniques using energy and curved suction devices for lobectomy (A) and using a stapler to divide the right anterior trunk of the pulmonary artery (B).
Figure 3Subcarinal lymph node dissection after right lower lobectomy. (A) Lymph nodes were dissected with an energy device, using a suction device for pushing or pulling. (B) Subcarinal area after removal of subcarinal lymph nodes.
Clinicopathological characteristics of patients with non-small cell lung cancer who underwent anatomical resection with uniportal VATS
| Variables | Mean (±SD) or N (%) |
|---|---|
| Age (±SD), years | 63.66 (±11.0) |
| Sex | |
| Male | 32 (37.6%) |
| Female | 53 (62.4%) |
| Current or former smoker | 29 (34.1%) |
| Involved lobe | |
| Right upper | 29 (34.1%) |
| Right middle | 6 (7.1%) |
| Right lower | 18 (21.2%) |
| Left upper | 19 (22.4%) |
| Left lower | 13 (15.3%) |
| Surgical procedures | |
| Segmentectomy | 17 (20.0%) |
| Lobectomy | 66 (77.6%) |
| Bilobectomy | 1 (1.2%) |
| Pneumonectomy | 1 (1.2%) |
| Mediastinal nodal evaluation | |
| No nodal dissection | 0 |
| Systematic nodal dissection | 71 (83.5%) |
| Selective nodal dissection | 14 (16.5%) |
| Pleural adhesion | |
| Whole lung adhesion | 5 (5.9%) |
| Partial adhesion | 25 (29.4%) |
| No adhesion | 55 (64.7%) |
| Histology | |
| Adenocarcinoma | 68 (80.0%) |
| Squamous cell carcinoma | 8 (9.4%) |
| Others | 9 (10.6%) |
| Stage | |
| 0 | 1 (1.2%) |
| IA | 54 (63.5%) |
| IB | 15 (17.6%) |
| IIA | 1 (1.2%) |
| IIB | 7 (8.2%) |
| IIIA | 6 (7.1%) |
| IIIB | 1 (1.2%) |
| Number of dissected lymph nodes (±SD) | 16.8 (±9.3) |
| Tumor location | |
| Central | 9 (10.6%) |
| Peripheral | 76 (89.4%) |
| Histological tumor grade | |
| Well differentiated carcinoma | 23 (27.1%) |
| Moderately differentiated carcinoma | 44 (51.8%) |
| Poorly differentiated carcinoma | 18 (21.2%) |
VATS, video-assisted thoracoscopic surgery; SD, standard deviation.
Perioperative and postoperative outcomes of uniportal VATS for lung cancer
| Variables | Uniportal VATS (n=85) |
|---|---|
| Anesthetic duration (min) (±SD) | 192.9 (±48.6) |
| Operative time (min) (±SD) | 153.9 (±46.0) |
| Intraoperative blood loss (mL) (±SD) | 84.4 (±93.6) |
| Conversion to multiportal VATS | 0 |
| Conversion to open thoracotomy | 0 |
| Postoperative chest drainage (day) (±SD) | 4.1 (±3.9) |
| Postoperative hospital stay (day) (±SD) | 6.5 (±5.4) |
| Postoperative complications, n (%) | 18 (21.2) |
| Pneumonia | 4 (4.7) |
| Prolonged air leak (>5 days) | 3 (3.5) |
| Acute respiratory distress syndrome | 2 (2.4) |
| Postoperative bleeding, n (%) | 2 (2.4) |
| Vocal cord palsy, n (%) | 2 (2.4) |
| Chylothorax, n (%) | 2 (2.4) |
| Delayed pneumothorax | 1 (1.2) |
| Subcutaneous emphysema, n (%) | 1 (1.2) |
| Atrial fibrillation, n (%) | 1 (1.2) |
| Operative mortality, n (%) | 2 (2.4) |
SD, standard deviation.
Comparison of surgical outcomes according to involved lobes
| Variables | RUL | RML | RLL | LUL | LLL | P |
|---|---|---|---|---|---|---|
| Operative time (min) (±SD) | 169.8 (±52.0) | 132.3 (±13.6) | 138.8 (±43.2) | 169.7 (±51.3) | 141.0 (±28.5) | 0.087 |
| Intraoperative blood loss (mL) (±SD) | 111.3 (±144.6) | 70.0 (±46.9) | 59.4 (±43.7) | 133.3 (±100.8) | 60.9 (±47.0) | 0.218 |
| Postoperative chest drainage (day) (±SD) | 4.4 (±5.6) | 3.2 (±1.2) | 5.4 (±4.7) | 3.3 (±2.1) | 3.2 (±1.1) | 0.559 |
| Postoperative hospital stay (day) (±SD) | 8.4 (±8.2) | 4.8 (±1.7) | 7.7 (±6.1) | 6.1 (±2.6) | 4.7 (±1.7) | 0.385 |
RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe; SD, standard deviation.
Figure 4Scatter plot showing operative time (A) and intraoperative blood loss (B) of the uniportal VATS lobectomies performed by one surgeon from first to last cases.
Comparison of clinicopathological characteristics in patients undergoing uniportal VATS or multiportal VATS
| Variables | Uniportal VATS (n=85) | Multi-portal VATS (n=269) | P | |
|---|---|---|---|---|
| Age (±SD), years | 63.66 (±11.0) | 66.7 (±10.0) | 0.018 | |
| Sex, n (%) | 0.004 | |||
| Male | 32 (37.6) | 151 (56.1) | ||
| Female | 53 (62.4) | 118 (43.9) | ||
| Current or former smoker, n (%) | 29 (34.1) | 132 (49.1) | 0.018 | |
| Involved lobe, n (%) | 0.946 | |||
| Right upper | 29 (34.1) | 89 (33.1) | ||
| Right middle | 6 (7.1) | 13 (4.8) | ||
| Right lower | 18 (21.2) | 63 (23.4) | ||
| Left upper | 19 (22.4) | 62 (23.0) | ||
| Left lower | 13 (15.3) | 42 (15.6)) | ||
| Surgical procedures, n (%) | 0.816 | |||
| Segmentectomy | 17 (20.0) | 55 (20.4) | ||
| Lobectomy | 66 (77.6) | 202 (75.1) | ||
| Bilobectomy | 1 (1.2) | 9 (3.3) | ||
| Pneumonectomy | 1 (1.2) | 3 (1.1) | ||
| Mediastinal nodal evaluation, n (%) | 0.354 | |||
| No nodal dissection | 0 | 5 (1.9) | ||
| Systematic nodal dissection | 71 (83.5) | 208 (77.3) | ||
| Selective nodal dissection | 14 (16.5) | 56 (20.8) | ||
| Pleural adhesion, n (%) | 0.341 | |||
| Whole lung adhesion | 5 (5.9) | 26 (9.7) | ||
| Partial adhesion | 25 (29.4) | 92 (34.2) | ||
| No adhesion | 55 (64.7) | 151 (56.1) | ||
| Histology, n (%) | 0.214 | |||
| Adenocarcinoma | 68 (80.0) | 196 (72.9) | ||
| Squamous cell carcinoma | 8 (9.4) | 47 (17.5) | ||
| Others | 9 (10.6) | 26 (9.7) | ||
| Stage, n (%) | 0.116 | |||
| 0 | 1 (1.2) | 5 (1.9) | ||
| IA | 54 (63.5) | 130 (48.3) | ||
| IB | 15 (17.6) | 38 (14.1) | ||
| IIA | 1 (1.2) | 10 (3.7) | ||
| IIB | 7 (8.2) | 44 (16.4) | ||
| IIIA | 6 (7.1) | 33 (12.3) | ||
| IIIB | 1 (1.2) | 9 (3.3) | ||
| Number of dissected lymph nodes (±SD) | 16.8 (±9.3) | 14.6 (±7.9) | 0.030 | |
| Tumor location, n (%) | 0.172 | |||
| Central | 9 (10.6) | 46 (17.1) | ||
| Peripheral | 76 (89.4) | 223 (82.9) | ||
| Histological tumor grade, n (%) | 0.475 | |||
| Well differentiated carcinoma | 23 (27.1) | 63 (23.4) | ||
| Moderately differentiated carcinoma | 44 (51.8) | 131 (48.7) | ||
| Poorly differentiated carcinoma | 18 (21.2) | 75 (27.9) | ||
| Neoadjuvant chemotherapy, n (%) | 4 (4.7) | 19 (7.1) | 0.472 | |
VATS, video-assisted thoracoscopic surgery; SD, standard deviation.
Comparison of perioperative and postoperative results in patients undergoing uniportal VATS or multiportal VATS
| Variables | Uniportal VATS (n=85) | Multiportal VATS (n=282) | P |
|---|---|---|---|
| Anesthetic duration (min) (±SD) | 192.9 (±48.6) | 230.7 (±56.4) | <0.001 |
| Operative time (min) (±SD) | 153.9 (±46.0) | 183.9 (±54.7) | <0.001 |
| Intraoperative blood loss (mL) (±SD) | 84.4 (±93.6) | 147.6 (±220.4) | <0.001 |
| Conversion to open thoracotomy, n (%) | 0 | 24 (8.9) | 0.005 |
| Postoperative chest drainage (day) (±SD) | 4.1 (±3.9) | 5.0 (±5.1) | 0.117 |
| Postoperative hospital stay (day) (±SD) | 6.5 (±5.4) | 8.0 (±11.9) | 0.270 |
| Postoperative complications, n (%) | 18 (21.2) | 55 (20.4) | 1.000 |
| Operative mortality, n (%) | 2 (2.4) | 2 (0.7) | 0.244 |
VATS, video-assisted thoracoscopic surgery; SD, standard deviation.